Jobs

Abbott to cut 1,900 jobs amid 'significant headwinds'

January 26, 2011

Abbott will trim its workforce by approximately 1,900 positions in a restructuring exercise intended to streamline commercial and manufacturing operations. Abbott's US pharmaceutical business will shoulder most of the job cuts, which will happen over the next several years, a company spokesperson said.
 

Pfizer CEO Jeff Kindler steps down, biopharma head Ian Read steps up

December 06, 2010

Pfizer announced on Sunday that CEO Jeff Kindler has retired from the company, and that Ian Read, Pfizer's head of biopharmaceutical operations, will step into the role as president, CEO and director.
 

Novartis axing 1,400 US sales jobs due to product changes

November 30, 2010

Effective January 1, Novartis will reduce its US field force by 1,400 positions, the firm said, as it braces for patent expiries and shifts resources for product launches.
 

Roche details job cuts, passes Tamiflu to contract sales org

November 17, 2010

Roche detailed its "operational excellence" cost-cutting program in a statement today, which includes a reduction of 2,650 pharmaceutical sales and marketing jobs. In total, 6,300 jobs will be affected by the restructuring.
 

Sanofi-Aventis to cut 1,400 sales reps

October 11, 2010

Sanofi-Aventis will winnow its US sales forces down by 1,400, the company announced on Friday. The move follows layoffs in April of around 400 reps, and brings the total sales force headcount down to roughly 4,000. The Paris-based company employed approximately 6,500 US-based reps just one year ago.
 

Co-promotion deal gone bad: Cypress hands Savella over to Forest

August 05, 2010

California-based Cypress Bioscience ended its co-promotion agreement with Forest Laboratories on Savella (milnacipran), a fibromyalgia drug approved in January 2009. As a result, Cypress will cut 123 jobs.
 

Novartis announces new changes to US pharma biz

April 14, 2010

Following a full-scale realignment of its commercial model in 2009, Novartis will make new adjustments to its US pharmaceutical operations, including a change at the top: Ludwig Hantson, CEO and head of North American pharmaceuticals, will exit the company, a Novartis spokeswoman confirmed.
 

Ax falls at Merck as CEO talks sales cuts

January 07, 2010

Eight weeks after the completion of Merck's merger with Schering-Plough, the new company is making staff cuts while hinting of more in commercial and manufacturing areas.
 

Sanofi-Aventis sales cuts come due

December 01, 2009

Sanofi-Aventis is laying off 750, or nearly 12%, of its US sales reps, as the firm retrenches in the face of generic exposure on some of its lead products.
 

IMS Health restructuring after dismal Q2

July 24, 2009

IMS Health announced a streamlining of business operations in the wake of second quarter losses, which may include as many as 850 job losses.
 

Video Exclusive

Web Exclusives

Five industry experts advise specialty pharma company on digital strategy

April 20, 2012

Specialty pharma company POZEN assembled a crack team of experts to help shape its digital strategy. Not only did POZEN share with us the text from their contributions, but you can watch exclusive video clips of their valuable perspectives right here.
 

MM&M Awards 2011 HIghlights

The Best MM&M Awards Ever!

MAHF Ceremony 2012

Photos from the Medical Advertising Hall of Fame Awards ceremony
 
Popular Topics
Acquisition Adherence App Celebrity Clinical Trial Co-Marketing Diabetes Diagnostics Digital Direct To Consumer (DTC) Disease Awareness Downsize Education & Awareness FDA Government Guidance Health Plans HMOs Hospitals Insurers Law Marketing Research Medical Journal Mobile Sales Force